These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 25616721)

  • 1. Editorial: Siegfried Hoyer's concept of Alzheimer pathophysiology.
    Frölich L; Müller WE; Riederer P
    J Neural Transm (Vienna); 2015 Apr; 122(4):495-7. PubMed ID: 25616721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolism hypothesis of Alzheimer's disease: from the concept of central insulin resistance and associated consequences to insulin therapy.
    Morgen K; Frölich L
    J Neural Transm (Vienna); 2015 Apr; 122(4):499-504. PubMed ID: 25673434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Mechanisms of Intranasal Insulin in SAMP8 Mice.
    Rhea EM; Nirkhe S; Nguyen S; Pemberton S; Bammler TK; Beyer R; Niehoff ML; Morley JE; Farr SA; Banks WA
    J Alzheimers Dis; 2019; 71(4):1361-1373. PubMed ID: 31561374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The brain as an insulin-sensitive metabolic organ.
    Milstein JL; Ferris HA
    Mol Metab; 2021 Oct; 52():101234. PubMed ID: 33845179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal insulin in Alzheimer's disease: Food for thought.
    Chapman CD; Schiöth HB; Grillo CA; Benedict C
    Neuropharmacology; 2018 Jul; 136(Pt B):196-201. PubMed ID: 29180222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin mediated novel therapies for the treatment of Alzheimer's disease.
    Dubey SK; Lakshmi KK; Krishna KV; Agrawal M; Singhvi G; Saha RN; Saraf S; Saraf S; Shukla R; Alexander A
    Life Sci; 2020 May; 249():117540. PubMed ID: 32165212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal insulin restores insulin signaling, increases synaptic proteins, and reduces Aβ level and microglia activation in the brains of 3xTg-AD mice.
    Chen Y; Zhao Y; Dai CL; Liang Z; Run X; Iqbal K; Liu F; Gong CX
    Exp Neurol; 2014 Nov; 261():610-9. PubMed ID: 24918340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal Insulin for Alzheimer's Disease.
    Hallschmid M
    CNS Drugs; 2021 Jan; 35(1):21-37. PubMed ID: 33515428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal insulin as a therapeutic option in the treatment of cognitive impairments.
    Benedict C; Frey WH; Schiöth HB; Schultes B; Born J; Hallschmid M
    Exp Gerontol; 2011; 46(2-3):112-5. PubMed ID: 20849944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis.
    Hoyer S
    J Neural Transm (Vienna); 1998; 105(4-5):415-22. PubMed ID: 9720971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease and insulin resistance: translating basic science into clinical applications.
    De Felice FG
    J Clin Invest; 2013 Feb; 123(2):531-9. PubMed ID: 23485579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence.
    Freiherr J; Hallschmid M; Frey WH; Brünner YF; Chapman CD; Hölscher C; Craft S; De Felice FG; Benedict C
    CNS Drugs; 2013 Jul; 27(7):505-14. PubMed ID: 23719722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of disturbed insulin signaling in animal models of Alzheimer's disease.
    Alves SS; Servilha-Menezes G; Rossi L; da Silva Junior RMP; Garcia-Cairasco N
    Neurosci Biobehav Rev; 2023 Sep; 152():105326. PubMed ID: 37479008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease.
    Moreira PI; Duarte AI; Santos MS; Rego AC; Oliveira CR
    J Alzheimers Dis; 2009; 16(4):741-61. PubMed ID: 19387110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease.
    Hölscher C
    Biochem Soc Trans; 2011 Aug; 39(4):891-7. PubMed ID: 21787319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease and diabetes: an integrative view of the role of mitochondria, oxidative stress, and insulin.
    Moreira PI
    J Alzheimers Dis; 2012; 30 Suppl 2():S199-215. PubMed ID: 22269163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Memory function and brain glucose metabolism.
    Hoyer S
    Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S62-7. PubMed ID: 13130391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain metabolism and brain disease: is metabolic deficiency the proximate cause of Alzheimer dementia?
    Blass JP
    J Neurosci Res; 2001 Dec; 66(5):851-6. PubMed ID: 11746411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired neuronal insulin signaling precedes Aβ42 accumulation in female AβPPsw/PS1ΔE9 mice.
    Chua LM; Lim ML; Chong PR; Hu ZP; Cheung NS; Wong BS
    J Alzheimers Dis; 2012; 29(4):783-91. PubMed ID: 22337827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.